Mark C. Schneyer - Net Worth and Insider Trading
Mark C. Schneyer Net Worth
The estimated net worth of Mark C. Schneyer is at least $868,290 dollars as of 2024-11-29. Mark C. Schneyer is the EVP, CHIEF FINANCIAL OFFICER of ACADIA Pharmaceuticals Inc and owns about 53,302 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $868,290. Details can be seen in Mark C. Schneyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark C. Schneyer has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark C. Schneyer
Mark C. Schneyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark C. Schneyer owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Mark C. Schneyer’s form 4 insider trades.
Insider Ownership Summary of Mark C. Schneyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | Chief Financial Officer |
Mark C. Schneyer Latest Holdings Summary
Mark C. Schneyer currently owns a total of 1 stock. Mark C. Schneyer owns 53,302 shares of ACADIA Pharmaceuticals Inc (ACAD) as of November 19, 2024, with a value of $868,290.
Latest Holdings of Mark C. Schneyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | 53,302 | 16.29 | 868,290 |
Holding Weightings of Mark C. Schneyer
Mark C. Schneyer Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark C. Schneyer has made a total of 15 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 10,259 shares on November 19, 2024, which brought Mark C. Schneyer around $172,454.
Insider Trading History of Mark C. Schneyer
- 1
Mark C. Schneyer Trading Performance
Mark C. Schneyer Ownership Network
Mark C. Schneyer Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Mark C. Schneyer is the Chief Financial Officer of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Principal Accounting Officer James Kihara , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Mark C. Schneyer made 10 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 49,474. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 319,936 shares made by Stephen Davis , a net sale of 37,363 shares made by Brendan Teehan , and a net sale of 15,648 shares made by James Kihara .
In summary, during the past 3 months, insiders sold 24,661 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 24,661 shares. During the past 18 months, 443,880 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 443,880 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Mark C. Schneyer Mailing Address
Above is the net worth, insider trading, and ownership report for Mark C. Schneyer. You might contact Mark C. Schneyer via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
